NT5E and pancreatic neoplasm: The choice of NT5E/CD73 as a potential cancer biomarker was supported by previous findings that three out of five pancreatic cancer cell lines released more peptides of NT5E/CD73 in the secretomes, compared to normal epithelial model cells HPDE (Klein-Scory, S. unpublished data).